SCHEMBL22758192

SCHEMBL22758192

CC(C)c1cnc2ccccc2c1C(C)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
GPR3 P46089 1/20 0.41
MALT1 Q9UDY8 2/20 0.40
LRRK2 Q5S007 1/20 0.39
ERN1 O75460 1/20 0.38
USP5 P45974 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
TSHR P16473 2/20 0.35
MPO P05164 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
TOP2A P11388 2/20 0.35
GALR3 O60755 1/20 0.34
NR2F2 P24468 1/20 0.34
BCAT2 O15382 1/20 0.34
SORD Q00796 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL827432 0.87 KDM4E (0.45) KDM4EGPR3MALT1LRRK2ERN1
SCHEMBL17301303 0.82 KDM4E (0.41) KDM4EGPR3MALT1LRRK2ERN1
SCHEMBL17301308 0.81 NCF1 (0.43) KDM4EGPR3MALT1LRRK2ERN1
SCHEMBL22758308 0.79 MALT1 (0.41) KDM4EGPR3MALT1LRRK2ERN1
SCHEMBL22758229 0.79 MALT1 (0.41) KDM4EGPR3MALT1LRRK2ERN1
SCHEMBL7562575 0.78 TLR7 (0.39) KDM4EGPR3MALT1ALDH1A1HPGD
SCHEMBL21364626 0.78 KDM4E (0.44) KDM4EGPR3LRRK2ERN1USP5
SCHEMBL22758197 0.77 MALT1 (0.45) MALT1
SCHEMBL23682757 0.76 ERN1 (0.50) KDM4EGPR3MALT1LRRK2ERN1
SCHEMBL15445437 0.76 KDM4E (0.42) KDM4EGPR3LRRK2ERN1USP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11248007-B2 Inhibitors of MALT1 and uses thereof CORNELL UNIVERSITY (US) 2022-02-15 US disclosed
US-20200385405-A1 INHIBITORS OF MALT1 AND USES THEREOF CORNELL UNIVERSITY (US) 2020-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200385405-A1 INHIBITORS OF MALT1 AND USES THEREOF MALT1, BCL6, BCL3 KDM4E 1844/4885GPR3 3780/4885MALT1 1/4885
US-11248007-B2 Inhibitors of MALT1 and uses thereof MALT1, BCL6, BCL3 KDM4E 1844/4885GPR3 3780/4885MALT1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.